Relative Risk vs. Return Landscape
If you would invest 9,169
in Alexion Pharmaceuticals Inc on April 21, 2013
and sell it today you would earn a total of 834
from holding Alexion Pharmaceuticals Inc or generate 9.1%
return on investment over 30
days. Alexion Pharmaceuticals Inc is currenly generating 0.53% of daily expected returns and assumes 3.17% risk (volatility on return distribution) over the 30 days horizon. In different words, 41% of equities are less volatile than Alexion Pharmaceuticals Inc and 70% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Given investment horizon of 30 days, Alexion Pharmaceuticals Inc is expected to generate 5.76 times more return on investment than the market. However, the company is 5.76 times more volatile than its market benchmark. It trades about 0.17 of its potential returns per unit of risk. The S&P 500 is currently generating roughly 0.56 per unit of risk.
Alexion Operating Margin
Based on recorded statements Alexion Pharmaceuticals Inc has Operating Margin of 35.28%. This is 232.09% lower than that of Healthcare sector, and 136.7% lower than that of Biotechnology
industry, The Operating Margin for all stocks is 1110.89% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Alexion Return On Equity vs Return On Asset
Alexion Pharmaceuticals Inc is rated below average
in return on equity category among related companies. It is rated fifth
in return on asset category among related companies reporting about 0.76
of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Alexion Pharmaceuticals Inc is roughly 1.31